Skip to main content
. 2019 May 2;30(6):e88. doi: 10.3802/jgo.2019.30.e88

Table 2. Summary of BLS-M07 dose escalation.

BLS-M07 dose (mg) No. of patients DLTs* and treatment-related SAEs
500 4 None
1,000 3 None
1,500 3 None, grade 1 premenstrual pain (2 patients)

DLS, dose-limiting toxicity; SAE, severe adverse event.

*DLT: any drug related grade 3 or higher toxicities.